158 related articles for article (PubMed ID: 36579550)
1. A novel NGS-based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients.
Zhang X; Fan X; Sun C; Wang L; Miao Y; Wang L; Yang P; Xu Y; Ren X; Wu X; Xu S
J Pathol Clin Res; 2023 Mar; 9(2):108-120. PubMed ID: 36579550
[TBL] [Abstract][Full Text] [Related]
2. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases.
Yang CY; Yeh YC; Wang LC; Lin YY; Lin SY; Wang SY; Chu PY; Liu ZY; Su YC; Ho HL; Chou TY
Mod Pathol; 2023 Mar; 36(3):100047. PubMed ID: 36788096
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
[TBL] [Abstract][Full Text] [Related]
4. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
[TBL] [Abstract][Full Text] [Related]
5. Does histological assessment accurately distinguish separate primary lung adenocarcinomas from intrapulmonary metastases? A study of paired resected lung nodules in 32 patients using a routine next-generation sequencing panel for driver mutations.
Bruehl FK; Doxtader EE; Cheng YW; Farkas DH; Farver C; Mukhopadhyay S
J Clin Pathol; 2022 Jun; 75(6):390-396. PubMed ID: 33649140
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
[TBL] [Abstract][Full Text] [Related]
7. Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.
Mansuet-Lupo A; Barritault M; Alifano M; Janet-Vendroux A; Zarmaev M; Biton J; Velut Y; Le Hay C; Cremer I; Régnard JF; Fournel L; Rance B; Wislez M; Laurent-Puig P; Herbst R; Damotte D; Blons H
J Thorac Oncol; 2019 May; 14(5):844-856. PubMed ID: 30721797
[TBL] [Abstract][Full Text] [Related]
8. Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?
Araujo-Filho JAB; Chang J; Mayoral M; Plodkowski AJ; Perez-Johnston R; Lobaugh S; Zheng J; Rusch VW; Rekhtman N; Ginsberg MS
Lung Cancer; 2021 Mar; 153():158-164. PubMed ID: 33529990
[TBL] [Abstract][Full Text] [Related]
9. Synchronous Pulmonary Adenocarcinomas.
Pagan CA; Shu CA; Crapanzano JP; Lagos GG; Stoopler MB; Rizvi NA; Heymann JJ; Sonett JR; Fernandes H; Saqi A
Am J Clin Pathol; 2020 Jun; 154(1):57-69. PubMed ID: 32146481
[TBL] [Abstract][Full Text] [Related]
10. Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.
Sun W; Feng L; Yang X; Li L; Liu Y; Lv N; Lin D
Hum Pathol; 2018 Nov; 81():261-271. PubMed ID: 30420048
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
[TBL] [Abstract][Full Text] [Related]
12. A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung Cancers With Multiple Pulmonary Sites of Involvement.
Suh YJ; Lee HJ; Sung P; Yoen H; Kim S; Han S; Park S; Hong JH; Kim H; Lim J; Kim H; Yoon SH; Jeon YK; Kim YT
J Thorac Oncol; 2020 Feb; 15(2):203-215. PubMed ID: 31634666
[TBL] [Abstract][Full Text] [Related]
13. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and molecular study for synchronous lung adenocarcinoma staging.
Donfrancesco E; Yvorel V; Casteillo F; Stachowicz ML; Patoir A; Tiffet O; Péoc'h M; Forest F
Virchows Arch; 2020 Jun; 476(6):835-842. PubMed ID: 31900636
[TBL] [Abstract][Full Text] [Related]
15. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
17. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
18. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
19. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
20. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
PeerJ; 2024; 12():e16808. PubMed ID: 38313018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]